| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Nurix Therapeutics, Inc. (NRIX) have been net sellers, shedding 49,260 shares worth roughly $1.2M on balance. In the past 30 days, 0 insiders bought and 4 sold.
All 4 insiders who sold still hold shares after their sales.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 123.5K | $3.19M | -6,861 | |
| CFO | 47.5K | $1.23M | -2,834 | |
| Other | 15.3K | $395.9K | -3,957 | |
| Dir | 10.8K | $277.6K | -22,583 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 5, 2021 | Gwenn Hansen70 | Chief Scientific Officer | Sale+OE | 400 | $35.00 | $14,000.00 | -2.8% | -33.1% | -59.7% | |
| Apr 1, 2021 | Gwenn Hansen70 | Chief Scientific Officer | Sale+OE | 400 | $31.55 | $12,620.00 | -2.8% | -14.5% | -55.0% | |
| Mar 16, 2021 | Gwenn Hansen70 | Chief Scientific Officer | Sale+OE | 800 | $45.00 | $36,000.00 | -5.5% | -34.9% | -69.3% | |
| Mar 10, 2021 | Christine Ring75 | General Counsel | Sale+OE | 2,000 | $41.27 | $82,539.36 | -71.3% | -28.4% | -68.3% | |
| Mar 8, 2021 | Pierre Beaurang64 | Chief Business Officer | Sale+OE | 7,500 | $37.02 | $277,678.49 | - | - | - | |
| Mar 1, 2021 | Gwenn Hansen70 | Chief Scientific Officer | Sale+OE | 800 | $35.95 | $28,760.00 | -5.5% | - | - | |
| Feb 24, 2021 | Hans van Houte56 | Chief Financial Officer | Sale+OE | 35,419 | $39.90 | $1,413,218.10 | - | - | - | |
| Feb 22, 2021 | Hans van Houte56 | Chief Financial Officer | Sale+OE | 5,330 | $39.93 | $212,839.16 | - | - | - | |
| Feb 18, 2021 | Christine Ring75 | General Counsel | Sale+OE | 2,000 | $35.88 | $71,750.35 | - | - | - | |
| Feb 18, 2021 | Pierre Beaurang64 | Chief Business Officer | Sale+OE | 15,000 | $35.49 | $532,351.76 | - | - | - |